- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Gujarat Themis Biosyn has announced a board meeting on strategic and leadership updates. CEO Tapas Guha Thakurata will resign by June-end due to health reasons. Dr. Sachin D. Patel is set to be re-designated as Managing Director for a five-year term from July 1, 2025, subject to shareholder approval. The board has reshuffled key committees and decided to withdraw the proposed merger with Themis Medicare, choosing to focus on organic growth in fermentation-based pharmaceutical intermediates and API businesses.